|
I do not live in the US so I am not directly involved but I do just want to say that cost effectiveness is a terrible concept. What price do you put on hope ?
In my opinion we should scrutenise the profit from pharmaceutical co and hospital charges before telling people that they are not worth such and such treatment.. The article says that the European use the cost effectiveness thingy, well this is simply wrong since in France for example cancer treatment have been ring-fenced which means cost is never a issue, but because the governement is buying they negociate cheaper prices..
If this is what is happening (hiding this bill inside the stimulus package) maybe I do not understand it well then I have to say that I am very disappointed with the way this law is being pushed through.. I hope that we are all missinformed about this, man I am so annoyed for you.. but I hope that I have completly missed the boat and not understood it because the contrary would be awful..
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
Last edited by fullofbeans; 02-12-2009 at 03:55 PM..
|